$EURK

Eureka Acquisition Corp (EURK): Entry into a Material Definitive Agreement

Eureka Acquisition Corp (EURK) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0002000410 00-0000000 0002000410 2026-06-12 2026-06-12 0002000410 EURK:UnitsConsistingOfOneClassOrdinaryShare0.0001ParValueAndOneRightToAcquireOnefifthOfOneClassOrdinaryShareMember 2026-06-12 2026-06-12 0002000410 EURK:ClassOrdinarySharesParValue0.0001PerShareMember 2026-06

Original reporting
Published Jun 23, 2026, 10:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 10:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$EURK
Neutral
low confidence
Mentioned
$EURK
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EURKNeutralLow
01

Why it matters

The amendment revises requirements for post-closing directors (section 5.19). The filing does not mention changes to deal economics, financing, or closing timeline, so impact is likely governance-focused and incremental.

02

Market read

This is a fresh SEC disclosure for EURK that updates deal governance terms; it may modestly affect perceived execution risk but lacks economic/timing changes.

03

What to watch

Traders should check the attached Exhibit 2.1 for any hidden changes to director selection mechanics, voting thresholds, or related conditions that could affect closing probability.

Relevance 6/10Novelty 4/10Timing: today’s SEC 8-K filing (June 23, 2026)

Background

The SPAC previously disclosed a business combination agreement (BCA) dated Oct. 29, 2025 with Marine Thinking Inc. and an amalgamation sub; this 8-K reports Amendment No. 1 dated June 12, 2026.

Company-level read

Ticker impact

$EURKNeutralLow confidence
Context

Eureka Acquisition Corp filed an 8-K disclosing Amendment No. 1 to its business combination agreement, revising post-closing director requirements.

Expected impact

Likely limited near-term impact unless the amendment signals broader governance/closing negotiations; watch for follow-on filings detailing deal terms.

Evidence & confidence

The filing only states a revision to section 5.19 regarding post-closing directors; it does not disclose changes to consideration, conditions, or timing.

Market effects

Minor read-through for SPAC governance/merger mechanics; no sector-wide datapoint beyond one deal amendment.

None indicated.

None indicated.

Counterpoint

Because the amendment is narrowly focused on post-closing directors, it may be routine housekeeping rather than a meaningful shift in deal risk.

Key entities

  • Eureka Acquisition Corp

    SPAC registrant filing the 8-K and entering Amendment No. 1 to its BCA.

  • Marine Thinking Inc.

    Counterparty in the BCA whose agreement was amended.

Related articles

$MPLTMedAI 8/10

MapLight Raises $150 M PIPE To Fund CNS Pipeline

MapLight Therapeutics (MPLT) priced a $150 million PIPE, selling 9.2M shares at $11.38 and 4.0M pre-funded warrants at $11.3799, exercisable at $0.0001 with no expiration. Proceeds will fund CNS drug ML-007C-MA, including VISTA Phase 2 in Alzheimer’s disease psychosis and ZEPHYR-2 Phase 3 in schizophrenia. Closing expected Aug. 14, 2026.

$TSNMedAI 8/10

Tyson Foods will close or sell three US beef facilities as industry struggles

Tyson Foods said it will close or sell three US beef facilities, ending operations at Joslin, Illinois and Eagle Mountain, Utah, and pursuing the sale of Pasco, Washington, while shifting capacity to other sites. The move follows prior Tyson beef shutdowns and comes as a 75-year cattle supply trough drives losses. Tyson forecast a $500m to $650m adjusted beef operating loss for fiscal 2026.

$MVISMedAI 8/10

MicroVision, Inc.: MicroVision Announces Launch of Proposed Public Offering

MicroVision (NASDAQ:MVIS) said it has commenced a proposed public offering of units, each unit consisting of one share of common stock (or a pre-funded warrant in lieu) and one warrant to buy one share. MicroVision will sell the shares and warrants, with final terms to be set at pricing. Net proceeds are for general corporate purposes, including working capital and capex.

$ORCLMed

Oracle planning new round of layoffs in August 2026

Oracle plans another layoff round in August 2026, according to Business Insider citing internal documents and people familiar with the plans. It says some teams could face double-digit cuts, with managers asked to identify affected employees ahead of Sept. 1. Oracle previously cut 21,000 jobs and recorded $1.8B restructuring charges. Oracle is funding AI data centers with large debt and equity.

$TSNMed

Tyson Foods to close 2 facilities, pursue sale of another amid 'historic' cattle shortage

Tyson Foods said it will close its Joslin, Illinois beef plant and its Eagle Mountain, Utah case-ready facility, and is pursuing the sale of its Pasco, Washington beef facility, citing strategic changes to its beef network amid a “historic” cattle shortage. Tyson plans to shift capacity to Dakota City, Nebraska; Holcomb, Kansas; and Amarillo, Texas, and ramp a second shift in Amarillo, according to the company.

$KPTIHighAI 9/10

It's crunch time for Karyopharm as company faces potential default next month

Karyopharm Therapeutics reported Q2 results showing a $67 million loss and cash reserves of $65.4 million. A $15.8 million loan payment is due Sept. 10, and without financing or a waiver the company says it would breach a $10.0 million liquidity covenant and could default. It is negotiating with lenders and pursuing Xpovio label expansion; Q2 Xpovio sales were $30.8 million.